{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T09:36:22Z","timestamp":1774172182826,"version":"3.50.1"},"reference-count":45,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In a randomized, placebo-controlled, crossover study under metabolic ward conditions, 10 GH-deficient adults received 1-wk GH replacement therapy (9.5 \u03bcg\/kg\u00b7d). The effect of this treatment on the erythrocyte sodium\/lithium countertransport (SLC) activity and on serum levels of adiponectin, resistin, leptin, IGF binding protein-1 (IGFBP-1) and IL-6 was determined.<\/jats:p>\n               <jats:p>The 1-wk GH replacement impaired glucose homeostasis determined from an oral glucose tolerance test. The other measured variables in serum were unchanged by GH replacement. At baseline, serum adiponectin level was inversely correlated and serum leptin level was positively correlated with measures of glucose tolerance and insulin sensitivity. The changes in serum leptin level and erythrocyte SLC activity were positively correlated, and the change in serum IGFBP-1 level was negatively correlated, correlated with changes in measures of glucose metabolism.<\/jats:p>\n               <jats:p>In conclusion, short-term GH treatment induced glucose intolerance but did not significantly change the erythrocyte SLC activity and the serum levels of adipokines, arguing against direct effects of GH on these measures. However, baseline values or changes in erythrocyte SLC activity, adiponectin, leptin, and IGFBP-1 correlated with glucose metabolism. This suggests that these factors are of importance for glucose homeostasis in GH-deficient adults, most likely through GH-independent mechanisms.<\/jats:p>","DOI":"10.1210\/jc.2004-1239","type":"journal-article","created":{"date-parts":[[2005,4,6]],"date-time":"2005-04-06T23:32:44Z","timestamp":1112830364000},"page":"2290-2296","source":"Crossref","is-referenced-by-count":17,"title":["Adiponectin, Leptin, and Erythrocyte Sodium\/Lithium Countertransport Activity, But Not Resistin, Are Related to Glucose Metabolism in Growth Hormone-Deficient Adults"],"prefix":"10.1210","volume":"90","author":[{"given":"Johan","family":"Svensson","sequence":"first","affiliation":[{"name":"Research Centre for Endocrinology and Metabolism (J.S., G.J.), SE-413 45 Go\u0308teborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Herlitz","sequence":"additional","affiliation":[{"name":"Departments of Nephrology (H.H.), SE-413 45 Go\u0308teborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per-Arne","family":"Lundberg","sequence":"additional","affiliation":[{"name":"Clinical Chemistry (P.-A.L.), Sahlgrenska University Hospital, SE-413 45 Go\u0308teborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[{"name":"Research Centre for Endocrinology and Metabolism (J.S., G.J.), SE-413 45 Go\u0308teborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071616354336600_R1","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0026-0495(93)90197-V","article-title":"Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.","volume":"42","author":"Fowelin","year":"1993","journal-title":"Metabolism"},{"key":"2020071616354336600_R2","first-page":"975","article-title":"The effects of 3 months treatment of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults. A minimal model analysis.","volume":"79","author":"O\u2032Neal","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616354336600_R3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2265.1998.00460.x","article-title":"Effects of four years treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.","volume":"48","author":"Al-Shoumer","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616354336600_R4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2265.1999.00595.x","article-title":"A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.","volume":"50","author":"Bu\u0308low","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616354336600_R5","first-page":"153","article-title":"The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.","volume":"80","author":"Weaver","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616354336600_R6","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1210\/jcem.85.11.6930","article-title":"The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.","volume":"85","author":"Rosenfalck","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616354336600_R7","first-page":"3285","article-title":"Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience.","volume":"82","author":"Hwu","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616354336600_R8","first-page":"1668","article-title":"Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.","volume":"83","author":"Christopher","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616354336600_R9","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1210\/jcem.87.5.8482","article-title":"Effects of 7 years of GH-replacement therapy on insulin sensitivity in GH-deficient adults.","volume":"87","author":"Svensson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616354336600_R10","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2337\/diabetes.50.10.2301","article-title":"Pharmacological antilipolysis restores insulin sensitivity after growth hormone exposure.","volume":"50","author":"Nielsen","year":"2001","journal-title":"Diabetes"},{"key":"2020071616354336600_R11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1210\/en.2003-0285","article-title":"Minireview: adiposity, inflammation, and atherogenesis.","volume":"144","author":"Lyon","year":"2003","journal-title":"Endocrinology"},{"key":"2020071616354336600_R12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue.","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"2020071616354336600_R13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy.","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"2020071616354336600_R14","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"key":"2020071616354336600_R15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"2020071616354336600_R16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes.","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"2020071616354336600_R17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/oby.2001.54","article-title":"Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion.","volume":"9","author":"Vozarova","year":"2001","journal-title":"Obes Res"},{"key":"2020071616354336600_R18","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00125-003-1228-z","article-title":"Regulation of adipocytokines and insulin resistance.","volume":"46","author":"Fasshauer","year":"2003","journal-title":"Diabetologia"},{"key":"2020071616354336600_R19","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1210\/jcem-71-6-1632","article-title":"Insulin-dependent regulation of insulin-like growth factor-binding protein-1.","volume":"71","author":"Snyder","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616354336600_R20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/cs1000443","article-title":"Sodium\/lithium countertransport, insulin resistance, insulin peptides and microalbuminuria in clinically healthy 58-year-old men.","volume":"100","author":"Herlitz","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"2020071616354336600_R21","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1152\/jappl.1999.87.3.1087","article-title":"Single- and multifrequency models for bioelectrical impedance analysis of body water compartments.","volume":"87","author":"Gudivaka","year":"1999","journal-title":"J Appl Physiol"},{"key":"2020071616354336600_R22","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/jcem.87.4.8394","article-title":"Growth hormone increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis.","volume":"87","author":"Johannsson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616354336600_R23","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/00004872-200310000-00018","article-title":"The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.","volume":"21","author":"Bergmann Sverrisdo\u0301ttir","year":"2003","journal-title":"J Hypertens"},{"key":"2020071616354336600_R24","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1056\/NEJM198004033021403","article-title":"Increased sodium-lithium countertransport in red cells of patients with essential hypertension.","volume":"302","author":"Canessa","year":"1980","journal-title":"N Engl J Med"},{"key":"2020071616354336600_R25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1994.tb02556.x","article-title":"Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin.","volume":"41","author":"Landin-Wilhelmsen","year":"1994","journal-title":"Clin Endocrinol"},{"key":"2020071616354336600_R26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1365-2265.1997.1851001.x","article-title":"Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test.","volume":"46","author":"Svensson","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616354336600_R27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2020071616354336600_R28","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616354336600_R29","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1365-2265.2003.01789.x","article-title":"Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance.","volume":"58","author":"Silha","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616354336600_R30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/eje.0.1500663","article-title":"Circulating adiponectin levels and cardiovascular risk factors in acromegalic patients.","volume":"150","author":"Ronchi","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2020071616354336600_R31","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1210\/jc.2003-030713","article-title":"Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients.","volume":"88","author":"Ede\u0301n Engstro\u0308m","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616354336600_R32","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2265.2004.02000.x","article-title":"The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.","volume":"60","author":"Hana","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616354336600_R33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1195-1155","article-title":"Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects.","volume":"1","author":"Maffei","year":"1995","journal-title":"Nat Med"},{"key":"2020071616354336600_R34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans.","volume":"334","author":"Considine","year":"1996","journal-title":"N Engl J Med"},{"key":"2020071616354336600_R35","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0026-0495(97)90128-1","article-title":"Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year.","volume":"46","author":"Fisker","year":"1997","journal-title":"Metabolism"},{"key":"2020071616354336600_R36","first-page":"363","article-title":"Effects of growth hormone (GH) and insulin-like growth factor-I on serum leptin in GH-deficient adults.","volume":"40","author":"Bianda","year":"1997","journal-title":"Diabetologia"},{"key":"2020071616354336600_R37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1046\/j.1365-2265.1996.830895.x","article-title":"Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency.","volume":"45","author":"Florkowski","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616354336600_R38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2265.1997.2281039.x","article-title":"Serum leptin concentrations in normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment.","volume":"47","author":"Nystro\u0308m","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616354336600_R39","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1126\/science.1092341","article-title":"Regulation of fasted blood glucose by resistin.","volume":"303","author":"Banerjee","year":"2004","journal-title":"Science"},{"key":"2020071616354336600_R40","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2337\/diabetes.53.8.1937","article-title":"Abnormal glucose homeostasis due to chronic hyperresistinemia.","volume":"53","author":"Rangwala","year":"2004","journal-title":"Diabetes"},{"key":"2020071616354336600_R41","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1210\/jc.2003-030519","article-title":"Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects.","volume":"88","author":"Lee","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616354336600_R42","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1210\/jc.2002-021604","article-title":"Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.","volume":"88","author":"Yannakoulia","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616354336600_R43","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2337\/diabetes.53.5.1279","article-title":"High serum resistin is associated with with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.","volume":"53","author":"Courten","year":"2004","journal-title":"Diabetes"},{"key":"2020071616354336600_R44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1365-2265.2003.01832.x","article-title":"Increased interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness.","volume":"59","author":"Leonsson","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616354336600_R45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.","volume":"133","author":"Sesmilo","year":"2000","journal-title":"Ann Intern Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/90\/4\/2290\/10775565\/jcem2290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/90\/4\/2290\/10775565\/jcem2290.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:20:14Z","timestamp":1594956014000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/90\/4\/2290\/2836890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,1]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2004-1239","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,1]]}}}